This study, sponsored by Maastricht University Medical Center, aims to elucidate the role of plant sterols in modulating the expression of the GPR146 gene, which is implicated in cholesterol metabolism. The findings could have significant implications for dietary interventions targeting cholesterol management, potentially leading to new dietary supplements or therapeutic strategies. The market for cholesterol-lowering products is substantial, with increasing consumer awareness around cardiovascular health. Competitive analysis should focus on existing cholesterol management products and dietary supplements, particularly those leveraging plant-based ingredients. Diligence should assess the regulatory landscape for dietary supplements and any potential claims that could arise from the study's outcomes.